info

Yes No
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Você está prestes a deixar o site local do Brasil e será direcionado ao site global. Deseja continuar?
Não exibir esta mensagem novamente
Sim
Não

Voce Buscou por:

Buscar

You Searched For:

Refinar por:

INFORMAÇÕES RELACIONADAS

CONTATOS PRINCIPAIS

PRÓXIMOS EVENTOS

PRODUTOS RELACIONADOS

Produtos Farmacêuticos - Minnesota

Destaques
Relatórios
Empresas
Refine sua pesquisa por Segmento de Mercado para obter a Atividade de Rating e Watchlist correspondentes
Visualizar Todos
  DataTipo de Documento Título Emissor/Entidade
22 Feb 2024 Credit Opinion ANI Pharmaceuticals, Inc.: Update to credit analysis following change of outlook to positive ANI Pharmaceuticals, Inc.
20 Feb 2024 Rating Action Moody's revises ANI Pharmaceuticals' outlook to positive; affirms B2 CFR ANI Pharmaceuticals, Inc.
27 Jul 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers AbbVie Inc.
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
Bausch Health C...
...
18 Apr 2023 Credit Opinion ANI Pharmaceuticals, Inc.: Update to credit analysis ANI Pharmaceuticals, Inc.
04 Oct 2022 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers AbbVie Inc.
Akorn Operating...
Alkermes, Inc.
Alvogen Pharma ...
Amgen Inc.
Amneal Pharmace...
ANI Pharmaceuti...
Azurity Pharmac...
Bausch + Lomb C...
Bausch Health A...
...
28 Apr 2022 Credit Opinion ANI Pharmaceuticals, Inc.: Update to credit analysis ANI Pharmaceuticals, Inc.
10 Nov 2021 Announcement of Periodic Review Moody's announces completion of a periodic review of ratings of ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc.
04 Nov 2021 Announcement Moody's: ANI's FDA approval of Purified Cortrophin Gel is credit positive ANI Pharmaceuticals, Inc.
03 Nov 2021 Issuer Comment ANI Pharmaceuticals, Inc.: ANI's FDA approval of Cortrophin Gel is credit positive ANI Pharmaceuticals, Inc.
28 Apr 2021 Credit Opinion ANI Pharmaceuticals, Inc.: New Issuer ANI Pharmaceuticals, Inc.
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry

    Moody's Integrity Hotline

    Via the Internet: 
    https://Moodys.ethicspoint.com
    By telephone from the United States: 
    Dial 1-866-330-MDYS (1-866-330-6397)
    By telephone from outside the United States:  
    
Dial the AT&T Direct Dial Access® code for your location.

Then, at the prompt, dial 866-330-MDYS (866-330-6397).
    HomePesquisa e RatingsProdutos e SoluçõesNotícias e Eventoscarreiras na Moody’s
    Ajuda e SuporteContate-nosApresente uma reclamação
    Termos de UsoPolítica de PrivacidadeDireitos Autorais
    © 2024 Moody's Investors Service, Inc., Moody’s Analytics, Inc. e/ou afiliadas e licenciadas. Todos os direitos reservados.